The Emerging Scenario of the Gut–Brain Axis: The Therapeutic Actions of the New Actor Kefir against Neurodegenerative Diseases

The fact that millions of people worldwide suffer from Alzheimer’s disease (AD) or Parkinson’s disease (PD), the two most prevalent neurodegenerative diseases (NDs), has been a permanent challenge to science. New tools were developed over the past two decades and were immediately incorporated into r...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Thiago M. C. Pereira, Larissa Z. Côco, Alyne M. M. Ton, Silvana S. Meyrelles, Manuel Campos-Toimil, Bianca P. Campagnaro, Elisardo C. Vasquez
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
Acceso en línea:https://doaj.org/article/f1afbed199e54f1a8ad543881896922e
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f1afbed199e54f1a8ad543881896922e
record_format dspace
spelling oai:doaj.org-article:f1afbed199e54f1a8ad543881896922e2021-11-25T16:29:46ZThe Emerging Scenario of the Gut–Brain Axis: The Therapeutic Actions of the New Actor Kefir against Neurodegenerative Diseases10.3390/antiox101118452076-3921https://doaj.org/article/f1afbed199e54f1a8ad543881896922e2021-11-01T00:00:00Zhttps://www.mdpi.com/2076-3921/10/11/1845https://doaj.org/toc/2076-3921The fact that millions of people worldwide suffer from Alzheimer’s disease (AD) or Parkinson’s disease (PD), the two most prevalent neurodegenerative diseases (NDs), has been a permanent challenge to science. New tools were developed over the past two decades and were immediately incorporated into routines in many laboratories, but the most valuable scientific contribution was the “waking up” of the gut microbiota. Disturbances in the gut microbiota, such as an imbalance in the beneficial/pathogenic effects and a decrease in diversity, can result in the passage of undesired chemicals and cells to the systemic circulation. Recently, the potential effect of probiotics on restoring/preserving the microbiota was also evaluated regarding important metabolite and vitamin production, pathogen exclusion, immune system maturation, and intestinal mucosal barrier integrity. Therefore, the focus of the present review is to discuss the available data and conclude what has been accomplished over the past two decades. This perspective fosters program development of the next steps that are necessary to obtain confirmation through clinical trials on the magnitude of the effects of kefir in large samples.Thiago M. C. PereiraLarissa Z. CôcoAlyne M. M. TonSilvana S. MeyrellesManuel Campos-ToimilBianca P. CampagnaroElisardo C. VasquezMDPI AGarticleoxidative stressinflammationneurodegenerative diseaseskefirchronic focal encephalitisangiotensin IITherapeutics. PharmacologyRM1-950ENAntioxidants, Vol 10, Iss 1845, p 1845 (2021)
institution DOAJ
collection DOAJ
language EN
topic oxidative stress
inflammation
neurodegenerative diseases
kefir
chronic focal encephalitis
angiotensin II
Therapeutics. Pharmacology
RM1-950
spellingShingle oxidative stress
inflammation
neurodegenerative diseases
kefir
chronic focal encephalitis
angiotensin II
Therapeutics. Pharmacology
RM1-950
Thiago M. C. Pereira
Larissa Z. Côco
Alyne M. M. Ton
Silvana S. Meyrelles
Manuel Campos-Toimil
Bianca P. Campagnaro
Elisardo C. Vasquez
The Emerging Scenario of the Gut–Brain Axis: The Therapeutic Actions of the New Actor Kefir against Neurodegenerative Diseases
description The fact that millions of people worldwide suffer from Alzheimer’s disease (AD) or Parkinson’s disease (PD), the two most prevalent neurodegenerative diseases (NDs), has been a permanent challenge to science. New tools were developed over the past two decades and were immediately incorporated into routines in many laboratories, but the most valuable scientific contribution was the “waking up” of the gut microbiota. Disturbances in the gut microbiota, such as an imbalance in the beneficial/pathogenic effects and a decrease in diversity, can result in the passage of undesired chemicals and cells to the systemic circulation. Recently, the potential effect of probiotics on restoring/preserving the microbiota was also evaluated regarding important metabolite and vitamin production, pathogen exclusion, immune system maturation, and intestinal mucosal barrier integrity. Therefore, the focus of the present review is to discuss the available data and conclude what has been accomplished over the past two decades. This perspective fosters program development of the next steps that are necessary to obtain confirmation through clinical trials on the magnitude of the effects of kefir in large samples.
format article
author Thiago M. C. Pereira
Larissa Z. Côco
Alyne M. M. Ton
Silvana S. Meyrelles
Manuel Campos-Toimil
Bianca P. Campagnaro
Elisardo C. Vasquez
author_facet Thiago M. C. Pereira
Larissa Z. Côco
Alyne M. M. Ton
Silvana S. Meyrelles
Manuel Campos-Toimil
Bianca P. Campagnaro
Elisardo C. Vasquez
author_sort Thiago M. C. Pereira
title The Emerging Scenario of the Gut–Brain Axis: The Therapeutic Actions of the New Actor Kefir against Neurodegenerative Diseases
title_short The Emerging Scenario of the Gut–Brain Axis: The Therapeutic Actions of the New Actor Kefir against Neurodegenerative Diseases
title_full The Emerging Scenario of the Gut–Brain Axis: The Therapeutic Actions of the New Actor Kefir against Neurodegenerative Diseases
title_fullStr The Emerging Scenario of the Gut–Brain Axis: The Therapeutic Actions of the New Actor Kefir against Neurodegenerative Diseases
title_full_unstemmed The Emerging Scenario of the Gut–Brain Axis: The Therapeutic Actions of the New Actor Kefir against Neurodegenerative Diseases
title_sort emerging scenario of the gut–brain axis: the therapeutic actions of the new actor kefir against neurodegenerative diseases
publisher MDPI AG
publishDate 2021
url https://doaj.org/article/f1afbed199e54f1a8ad543881896922e
work_keys_str_mv AT thiagomcpereira theemergingscenarioofthegutbrainaxisthetherapeuticactionsofthenewactorkefiragainstneurodegenerativediseases
AT larissazcoco theemergingscenarioofthegutbrainaxisthetherapeuticactionsofthenewactorkefiragainstneurodegenerativediseases
AT alynemmton theemergingscenarioofthegutbrainaxisthetherapeuticactionsofthenewactorkefiragainstneurodegenerativediseases
AT silvanasmeyrelles theemergingscenarioofthegutbrainaxisthetherapeuticactionsofthenewactorkefiragainstneurodegenerativediseases
AT manuelcampostoimil theemergingscenarioofthegutbrainaxisthetherapeuticactionsofthenewactorkefiragainstneurodegenerativediseases
AT biancapcampagnaro theemergingscenarioofthegutbrainaxisthetherapeuticactionsofthenewactorkefiragainstneurodegenerativediseases
AT elisardocvasquez theemergingscenarioofthegutbrainaxisthetherapeuticactionsofthenewactorkefiragainstneurodegenerativediseases
AT thiagomcpereira emergingscenarioofthegutbrainaxisthetherapeuticactionsofthenewactorkefiragainstneurodegenerativediseases
AT larissazcoco emergingscenarioofthegutbrainaxisthetherapeuticactionsofthenewactorkefiragainstneurodegenerativediseases
AT alynemmton emergingscenarioofthegutbrainaxisthetherapeuticactionsofthenewactorkefiragainstneurodegenerativediseases
AT silvanasmeyrelles emergingscenarioofthegutbrainaxisthetherapeuticactionsofthenewactorkefiragainstneurodegenerativediseases
AT manuelcampostoimil emergingscenarioofthegutbrainaxisthetherapeuticactionsofthenewactorkefiragainstneurodegenerativediseases
AT biancapcampagnaro emergingscenarioofthegutbrainaxisthetherapeuticactionsofthenewactorkefiragainstneurodegenerativediseases
AT elisardocvasquez emergingscenarioofthegutbrainaxisthetherapeuticactionsofthenewactorkefiragainstneurodegenerativediseases
_version_ 1718413175028711424